Scroll
Fertin Pharma A/S

Fertin Pharma A/S sold to Philip Morris International for DKK 5.1bn

 

Case

Fertin Pharma A/S sold to Philip Morris International for DKK 5.1bn

The private equity fund EQT has sold the Danish nicotine chewing gum manufacturer Fertin Pharma A/S to Philip Morris International for DKK 5.1bn.

Fertin Pharma A/S is a leading player within the manufacture of nicotine chewing gum. In addition, the company manufactures dietary supplements, cannabinoids etc. which, much like nicotine, are delivered to the consumer through chewing gum or tablets.

In 2016, EQT bought 70% of Fertin Pharma A/S from the Bagger-Sørensen family.

Philip Morris International is a multinational tobacco manufacturer that sells products in more than 180 countries. One of the company’s brands is Marlboro.

The transaction is subject to approval from the authorities.

Accura advised EQT in connection with the transaction.